Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Yuanpeng Li

2 papers in the library · 3 citations · publishing 2025

Papers

Utilizing Caenorhabditis Elegans as a Rapid and Precise Model for Assessing Amphetamine-Type Stimulants: A Novel Approach to Evaluating New Psychoactive Substances Activity and Mechanisms.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) May 1, 2025 Yuanpeng Li, Hongyuan Li, Hongshuang Wang et al. 3 citations

Amphetamine-type stimulants (ATS) and their analogs can be rapidly evaluated using the roundworm Caenorhabditis elegans. In a swimming-induced paralysis assay, worms exposed to amphetamine, methamphetamine, MDMA, and their enantiomers showed distinct behavioral responses depending on their genetic makeup. The effects depended on dopaminergic and serotonergic pathways, specifically the DOP-3 and SER-4 receptors. The assay also distinguished between chiral forms of ATS, and meta-R amphetamines produced stronger effects than ortho-R and para-R analogs. This method offers a cost-effective, high-throughput way to assess the activity and toxicity of new psychoactive substances.

Exploring the therapeutic potential of psychedelics in treating substance use disorders.

Molecular Psychiatry December 1, 2025 Yuanpeng Li, Hongyuan Li, Hongshuang Wang et al.

Psychedelics, especially psilocybin, show promise as treatments for substance use disorders (SUDs) including alcohol, nicotine, heroin, and cocaine. They may work by disrupting maladaptive neural circuits, promoting neuroplasticity, and enabling psychological insights that address root causes. Clinical trials indicate psilocybin-assisted therapy can significantly reduce substance use and improve mental health outcomes. However, legal barriers, safety concerns, and the need for more rigorous research remain. The outlook is cautiously optimistic, with potential to transform SUD therapy.